Biohaven Ltd.
For the period ended Dec 31, 2025. Filed Mar 2, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 2, 2026
BHVN$15.23+5.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
(Amounts in thousands, except share amounts)
| December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $229,957 | $99,134 |
| Marketable securities | 89,180 | 386,857 |
| Prepaid expenses | 47,022 | 49,376 |
| Other current assets | 2,170 | 3,105 |
| Total current assets | 368,329 | 538,472 |
| Property and equipment, net | 15,964 | 17,320 |
| Intangible assets | 18,400 | 18,400 |
| Goodwill | 1,390 | 1,390 |
| Other non-current assets | 47,364 | 39,525 |
| Total assets | $451,447 | $615,107 |
| Liabilities and Shareholders' Equity | ||
| Current liabilities: | ||
| Accounts payable | $11,643 | $18,029 |
| Accrued expenses and other current liabilities | 104,291 | 51,487 |
| Forward contract and derivative liability | — | 84,710 |
| Total current liabilities | 115,934 | 154,226 |
| Non-current operating lease liability | 39,958 | 32,782 |
| Notes payable | 238,900 | — |
| Other non-current liabilities | 4,583 | 4,663 |
| Total liabilities | 399,375 | 191,671 |
| Commitments and contingencies (Note 12) | ||
| Shareholders' Equity: | ||
| Preferred shares, no par value; 10,000,000 shares authorized, no shares issued and outstanding as of December 31, 2025 and 2024 | — | — |
| Common shares, no par value; 200,000,000 shares authorized as of December 31, 2025 and 2024; 132,775,113 and 101,221,989 shares issued and outstanding as of December 31, 2025 and 2024, respectively | 1,934,276 | 1,656,702 |
| Additional paid-in capital | 193,984 | 112,369 |
| Accumulated deficit | (2,084,536) | (1,345,714) |
| Accumulated other comprehensive income | 8,348 | 79 |
| Total shareholders' equity | 52,072 | 423,436 |
| Total liabilities and shareholders' equity | $451,447 | $615,107 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.